No interethnic differences in stereoselective disposition of oral nimodipine between Caucasian and Japanese subjects

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 4, 1996, Pages 163-171

  Muck W ^a   Tanaka, T ^b   Ahr, G ^a   Kuhlmann, J ^a  

^a BAYER AG   (Germany)

^b Clin Pharmacol Bayer Yakuhin L   (Japan)

Author keywords

Caucasians; Chinese; Ethnic groups; Japanese; Nimodipine enantiomers; Pharmacokinetics

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; ETHNIC GROUP; FEMALE; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; META ANALYSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; STEREOSPECIFICITY;

ADMINISTRATION, ORAL; ADULT; AGED; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NIMODIPINE; STEREOISOMERISM;

EID: 0029873679     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ahsan CH, Renwick AC, Waller DC et al 1993 The influences of dose and ethnic origins on the pharmacokinetics of nifedipine. Clin Pharmacol Ther 54: 329-338
2. Brosen K 1990 Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics. Clin Pharmacokinet 18: 220-239
3. Fischer C, Schönberger F, Mück W, Heuck K, Eichelbaum M 1993 Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique. J Pharm Sci 82: 244-250
4. Frost N, Ahr G, Weber H, Wingender W, Kuhlmann J 1990 Nisoldipine enantiomers - assessment of pharmacokinetics by stable isotope technique. In: Kuhlmann J, Wingender W (eds) Dose-response relationship of drugs. Zuckschwerdt, München, pp 87-92
5. Güngerich FP, Brian WR, Iwasaki M, Sari M-A, Bäärnhielm C, Berntsson P 1991 Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450IIIA4. J Med Chem 34: 1838-1844
6. Heinig R, Muschalek V, Ahr G 1994 Determination of the enantiomers of nisoldipine in human plasma using high-performance liquid chromatography on a chiral stationary phase and gas chromatography with mass-selective detection. J Cnromatogr 655: 286-292
7. Kleinbloesem CH, van Brummelen P, Faber H, Danhof M, Vermeulen NPE, Breimer DD 1984 Variability of nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol 33: 3721-3724
8. Kumana CR, Kou M, Yu YL et at 1993 Investigation of nimodipine pharmacokinetics in Chinese patients with acute subarachnoid haemorrhage. Eur J Clin Pharmacol 45: 363-366
9. Langley MS, Sorkin EM 1989 Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease. Drugs 37: 669-699
10. Lasseter KC, Shamblen EC, Krol GJ, Frost RW, Lettieri JT 1988 Pharmacokinetics of nimodipine and its metabolites at four different doses. J Clin Pharmacol 28: 917
11. Mast V, Fischer C, Mikus G, Eichelbaum M 1992 Use of pseudoracemic nitrendipine as a tool to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers. Br J Clin Pharmacol 33: 51-59
12. Mikus G, Mast V, Ratge D, Wisser H, Eichelbaum M 1995 Stereoselectivity in cardiovascular and biochemical action of calcium antagonists: studies with the enantiomers of the dihydropyridine nitrendipine. Clin Pharmacol Ther 57: 52-61
13. Mück W, Schmage N, Hörl W, Riegel W, Kuhlmann J 1992 Pharmacokinetics and hemodynamic effects of nimodipine in patients with renal impairment. Pharm Res 9: 329
14. Muck W, Bode H 1994 Bioanalytics of nimodipine - an overview of methods. Pharmazie 49: 130-139
15. Muck W 1995 Enantiospecific determination of nimodipine in human plasma by LC/MS-MS. J Chromatogr A 712: 45-53
16. Muck W, Ahr G, Kuhlmann J 1995 Nimodipine - potential for drug-drug interactions in the elderly. Drugs Aging 6:229-242
17. Muck W, Tanaka T, Ahr G, Kuhlmann J 1995 No interethnic differences in stereoselective disposition of oral nimodipine between Caucasian and Japanese subjects. Naunyn Schmiedeberg's Arch Pharmacol 351: R13
18. Naito C 1994 Ethnic differences on pharmacokinetic parameters. In: Walker S, Lumley C, McAuslane N (eds) The relevance of ethnic factors in the clinical evaluation of medicines. Kluwer, London, pp 161-178
19. Renwick AC, Robertson DRC, Macklin B, Challenor V, Waller DG, George CF 1988 The pharmacokinetics of oral nifedipine - a population study. Br J Clin Pharmacol 25: 701-708
20. Schellens JHM, Soons PA Breimer DD 1988 Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem Pharmacol 37: 2507-2510
21. Soons PA, Breimer DD 1991 Stereoselective pharmacokinetics of oral intravenous nitrendipine in healthy male subjects. Br J Clin Pharmacol 52: 11-16
22. Soons PA, Cohen AE, Breimer DD 1993a Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers. Eur J Clin Pharmacol 44: 113-120
23. Soons PA, Mulders TM, Uchida E, Schoemaker HC, Cohen AF, Breimer DD 1993b Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics. Eur J Clin Pharmacol 44: 163-169
24. Sporckmann K, Eichelbaum M 1991 Enantioselective disposition of R- and S-nimodipine after simultaneous oral and intravenous administration. Naunyn Schmiedeberg's Arch Pharmacol 343: R124
25. Tartara A et al 1991 Differential effects of valproic acid and enzyme inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients. Br J Clin Pharmacol 32: 335-340
26. Towart R, Wehinger E, Meyer H, Kazda S 1982 The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Drug Res 32: 338-346
27. Wadworth AN, McTavish D 1992 Nimodipine: a review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging 2: 262-286
28. Walker S, Lumley C, McAuslane N 1994 The relevance of ethnic factors in the clinical evaluation of medicines. Kluwer, London
29. Wood AJJ, Zhou HH 1991 Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 20: 350-373